Cargando…
Patient‐reported skin reactions to 5% 5‐fluorouracil in treatment of actinic keratosis
Autores principales: | Ahmady, S., Oyen, E.M.M., Jansen, M.H.E., Nelemans, P.J., Kessels, J.P.H.M., Kelleners‐Smeets, N.W.J., Mosterd, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292237/ https://www.ncbi.nlm.nih.gov/pubmed/34109609 http://dx.doi.org/10.1111/bjd.20570 |
Ejemplares similares
-
A trial‐based cost‐effectiveness analysis of topical 5‐fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands
por: Jansen, M.H.E., et al.
Publicado: (2020) -
The additional diagnostic value of optical coherence tomography in clinically diagnosed basal cell carcinomas undergoing direct surgical excision
por: Adan, F., et al.
Publicado: (2021) -
Development of a patient decision aid for superficial basal cell carcinoma
por: van Delft, L.C.J., et al.
Publicado: (2020) -
External validation of a model to predict risk of keratinocyte skin cancer after renal transplantation in a Western European cohort
por: Verhage, E.J., et al.
Publicado: (2020) -
Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
por: Azin, Marjan, et al.
Publicado: (2022)